IpsenOvjeren akaunt

@IpsenGroup

We are driven by a passion for improvement and innovation in solutions for those living with debilitating conditions. Terms of use:

Vrijeme pridruživanja: ožujak 2011.

Tweetovi

Blokirali ste korisnika/cu @IpsenGroup

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @IpsenGroup

  1. proslijedio/la je Tweet
    28. sij

    We invested €8.5 billion into cancer research in 2015 and , pushing the boundaries of science to improve patient outcomes

    Poništi
  2. 2. velj

    Since the development of our NET Symptom Index, clinicians and patient advocacy groups have approached us to integrate it in their studies, helping us further collaborate with the community. Read more:

    Poništi
  3. proslijedio/la je Tweet
    31. sij

    Cancer mortality in children has decreased by 50% since 1995. driving innovation to help children stay healthy, so they can play, go to school and live their childhood to the fullest

    Poništi
  4. 31. sij

    Working with patients, for patients, underlines everything we do at Ipsen. As part of our continued support of the community, we have developed a new Health Related Quality of Life tool called the NET Symptom Index to help patients and physicians manage and measure QoL.

    Poništi
  5. 21. sij

    Problems with paywalls? Not here. We’re proud to announce that we honored our commitment to accessibility and transparency with our 100% record for open-access publication in 2019.

    Poništi
  6. 15. sij

    Congratulations again to Ian Vela, recipient of our STEPS Program grant! We look forward to seeing him and all attendees this week at the 17th Meeting of the EAU Section of Oncological Urology in Dublin.

    Poništi
  7. 15. sij

    Head of Global Business Development Oncology, Elena Ritsou, discusses how joining other leaders at the 38th J.P. Morgan Healthcare Conference helps fuel Ipsen's external innovation strategy.

    Poništi
  8. 14. sij

    Here's what Eugenia Litz, Vice President Investor Relations at Ipsen, has to say about the importance of networking with industry peers at the 38th J.P. Morgan Healthcare Conference.

    Poništi
  9. 14. sij

    He’ll play a crucial role in delivering our global medical and patient safety strategy, engaging in structured, ethical and valuable dialogue with patients and caregivers. As a member of the ELT, Dr. Hildemann will actively contribute to the strategic direction of the company.

    Prikaži ovu nit
    Poništi
  10. 14. sij

    We’re delighted to announce the appointment of Dr. Steven Hildemann as Executive Vice President, Chief Medical Officer and Head of Global Medical Affairs and Pharmacovigilance as of March 1st.

    Prikaži ovu nit
    Poništi
  11. 13. sij

    Chief Executive Officer, Aymeric Le Chatelier, speaks about Ipsen's growth and trajectory for continued success on the first day of the 38th J.P. Morgan Healthcare Conference.

    Poništi
  12. 12. sij

    Tomorrow we'll be at the the largest healthcare investment symposium in the industry, bringing together the most influential industry leaders! Stay connected to get the latest from the 38th J.P. Morgan Healthcare Conference!

    Poništi
  13. 8. sij

    Over 75% of children with cerebral palsy experience spasticity, a muscle control disorder interfering with movement and speech. Spasticity can be particularly difficult for children, impacting the ability to perform daily tasks.

    Poništi
  14. 7. sij

    It's estimated that 12 million people worldwide are living with spasticity, a condition usually caused by damage to nerves in the brain or spinal cord that are responsible for our control over voluntary movement. Learn more:

    Poništi
  15. 6. sij

    Ipsen is committed to improving the lives of patients with spasticity and movement disorders. Read our latest announcement here:

    Poništi
  16. 1. sij

    Happy new year from the entire Ipsen family! 🎊 We're excited for another year of growth and innovation, and are more dedicated than ever to delivering improved patient outcomes.

    Poništi
  17. 20. pro 2019.

    Our commitment to patient centricity is exemplified by our colleagues around the world. For Ana, working at Ipsen means she can have a real impact on patients' lives.

    Poništi
  18. 18. pro 2019.

    In January, Lucie Keeber, Global Medical Affairs Director, Rare Diseases, will represent Ipsen as co-chair of a session at ‘Patients as Partners EU’ with Cathy Bouvier from . Find out more about here:

    Poništi
  19. 17. pro 2019.

    in educating people about . Marin lives with fibrodsyplasia ossificans progressiva, or , and you can listen to her story here.

    Poništi
  20. 15. pro 2019.

    Acromegaly can cause extremeties to grow larger, so an increased, rather than decreased, foot size is a sign of the condition. Find out more about acromegaly at acromunity:

    Prikaži ovu nit
    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·